Cargando…
Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma
In this study, we identified prognostic biomarkers in ovarian carcinoma by integrating multi-omics DNA copy number variation (CNV) and methylation variation (MET) data. CNV, MET, and messenger RNA (mRNA) expression were examined in 351 ovarian carcinoma patients. Genes for which expression was corre...
Autores principales: | Zheng, Mingjun, Hu, Yuexin, Gou, Rui, Wang, Jing, Nie, Xin, Li, Xiao, Liu, Qing, Liu, Juanjuan, Lin, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629004/ https://www.ncbi.nlm.nih.gov/pubmed/31257224 http://dx.doi.org/10.18632/aging.102047 |
Ejemplares similares
-
Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma
por: Zheng, Mingjun, et al.
Publicado: (2020) -
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019) -
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022) -
Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020) -
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
por: Wang, Shuang, et al.
Publicado: (2020)